Nothing Special   »   [go: up one dir, main page]

EE200000270A - Use of Escherichia coli strain DSM 6601 in the manufacture of a medicament - Google Patents

Use of Escherichia coli strain DSM 6601 in the manufacture of a medicament

Info

Publication number
EE200000270A
EE200000270A EEP200000270A EEP200000270A EE200000270A EE 200000270 A EE200000270 A EE 200000270A EE P200000270 A EEP200000270 A EE P200000270A EE P200000270 A EEP200000270 A EE P200000270A EE 200000270 A EE200000270 A EE 200000270A
Authority
EE
Estonia
Prior art keywords
escherichia coli
coli strain
medicament
manufacture
strain dsm
Prior art date
Application number
EEP200000270A
Other languages
Estonian (et)
Inventor
Proppert Hans
Original Assignee
Pharma-Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma-Zentrale Gmbh filed Critical Pharma-Zentrale Gmbh
Publication of EE200000270A publication Critical patent/EE200000270A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The invention relates to the use of the Escherichia coli strain DSM 6601 to produce medicaments for preventing and treating microbially-caused diarrhoea involving pathogenic fungi in animals.
EEP200000270A 1997-11-22 1998-11-18 Use of Escherichia coli strain DSM 6601 in the manufacture of a medicament EE200000270A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751907A DE19751907B4 (en) 1997-11-22 1997-11-22 Use of Escherichia coli strain DSM 6601 for the treatment of diarrhea in the veterinary sector
PCT/EP1998/007389 WO1999026642A1 (en) 1997-11-22 1998-11-18 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine

Publications (1)

Publication Number Publication Date
EE200000270A true EE200000270A (en) 2001-08-15

Family

ID=7849590

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000270A EE200000270A (en) 1997-11-22 1998-11-18 Use of Escherichia coli strain DSM 6601 in the manufacture of a medicament

Country Status (14)

Country Link
EP (1) EP1033993B1 (en)
JP (1) JP2001523726A (en)
AT (1) ATE206617T1 (en)
CZ (1) CZ290100B6 (en)
DE (2) DE19751907B4 (en)
DK (1) DK1033993T3 (en)
EE (1) EE200000270A (en)
ES (1) ES2165709T3 (en)
HK (1) HK1031996A1 (en)
HU (1) HUP0004366A3 (en)
NO (1) NO20002577L (en)
PL (1) PL340328A1 (en)
PT (1) PT1033993E (en)
WO (1) WO1999026642A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10328669B4 (en) * 2003-06-26 2005-12-01 Pharma-Zentrale Gmbh Plasmid-free clone of E. coli strain DSM 6601
MXPA06001821A (en) * 2003-08-18 2006-05-31 Bio Balance Corp A stable liquid probiotic composition, preparation and applications thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE19637936A1 (en) * 1996-09-17 1998-04-09 Lehr Claus Michael Prof Dr Pharmaceutical composition for mucosal application
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics

Also Published As

Publication number Publication date
CZ20001894A3 (en) 2000-11-15
HK1031996A1 (en) 2001-07-06
DE19751907B4 (en) 2004-07-08
HUP0004366A2 (en) 2001-04-28
NO20002577D0 (en) 2000-05-19
HUP0004366A3 (en) 2001-09-28
ATE206617T1 (en) 2001-10-15
CZ290100B6 (en) 2002-05-15
EP1033993B1 (en) 2001-10-10
EP1033993A1 (en) 2000-09-13
ES2165709T3 (en) 2002-03-16
PL340328A1 (en) 2001-01-29
DE59801718D1 (en) 2001-11-15
WO1999026642A1 (en) 1999-06-03
NO20002577L (en) 2000-07-18
DK1033993T3 (en) 2002-01-28
PT1033993E (en) 2002-03-28
DE19751907A1 (en) 1999-07-29
JP2001523726A (en) 2001-11-27

Similar Documents

Publication Publication Date Title
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
EP0713493A4 (en) Production of human hemoglobin in transgenic pigs
RS50091B (en) Use of retigabine for the treatment of neuropathic pain
IL122248A0 (en) Use of nisin for treating an infection
FI963232A0 (en) Acidified nitrite as an antimicrobial agent
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
BG101040A (en) Benzopyrans and their use as therapeutic agents
GB9425730D0 (en) Compounds
BG105275A (en) Tan-1057 derivatives
BG102667A (en) Diosgenine-containing composition
EE200000270A (en) Use of Escherichia coli strain DSM 6601 in the manufacture of a medicament
AU1278600A (en) Novel therapeutic application of nicergoline
HUP0100608A2 (en) Bactericidal and fungicidal n-(3-chloro-4-methylphenyl)-4-methyl-1,2,3-thiadiazole-5-karboxamide, plant disease controlling agent containing them and its use
HUP0003845A2 (en) Use of 8a-azalides as antimicrobial agents
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
MD980129A (en) Antiherpetic remedy
AU2177401A (en) Combination of riluzole and gabapentin and use thereof as medicine
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
IT1216096B (en) L_PIROGLUTAMIL_L_CISTEINA, DIPEPTIDE WITH HIGH ANTI-CATHATOGEN ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
BR0007491A (en) Use of 3-isoxazolidinones and hydroxylamic acids to treat infections
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
KR960700053A (en) APPLICATION OF RILUZOLE AS A RADIORESTORER
UA10259A (en) Neuropolyosm, antiedematous drug
RO120241B8 (en) Medicinal preparation with eutrophic and anabolic effect